LYMPHOMA HEMATOLOGY AND ONCOLOGY IN ANCHORAGE, AK

WHAT TO KNOW ABOUT OUR LYMPHOMA TREATMENT SERVICES

We at Alaska Oncology and Hematology, LLC are aware of the particular difficulties lymphoma patients must overcome. In order to achieve the greatest results, our method combines state-of-the-art medical procedures, sympathetic assistance, and a patient-centered mindset.

One kind of blood cancer that affects the lymphatic system, which is an essential component of the immune system, is lymphoma. The diagnosis, treatment, and management of both Hodgkin and non-Hodgkin lymphomas are our areas of expertise at Alaska Oncology and Hematology, LLC. Patients fighting this illness will receive thorough and individualized care from our committed team of medical professionals.

GET STARTED WITH OUR LYMPHOMA TREATMENT

Our skilled group of APPs, hematologists/oncologists, and other experts work closely together to create customized treatment programs for every patient. These treatment approaches could involve immunotherapy, chemotherapy, radiation therapy, targeted medicines, stem cell transplantation, or a mix of these. By actively taking part in clinical studies, we remain at the forefront of lymphoma research and provide our patients with access to cutting-edge medicines and expanded treatment options.

Additionally, we offer thorough supportive care services to address the psychological and physical effects of having cancer. Our mission is to assist our patients in achieving the highest quality of life by supporting them along their journey.

TREATMENT OPTIONS

1. Chemotherapy: This treatment employs medications to kill cancer cells. It can be given intravenously, orally, or in conjunction with other therapies. Chemotherapy medications can be tailored to target distinct subtypes of lymphoma.

2. Radiation therapy: To destroy cancer cells and reduce tumor size, radiation therapy uses high-energy X-rays or other radiation sources. It is frequently utilized to target particular disease-affected areas or in cases of limited lymphomas.

3. Immunotherapy: Immunotherapy uses the body's own defenses against cancer. Rituximab, obinutuzumab, and brentuximab vedotin are examples of monoclonal antibodies that precisely target cancer cells and designate them for immune system destruction.


4. Targeted Therapy: Drugs used in targeted therapy, like venetoclax, idelalisib, and ibrutinib, block particular chemicals or pathways that promote the growth of cancer. The molecular features of the lymphoma subtype are taken into account when designing these medicines.

5. Stem Cell Transplantation: This procedure uses healthy stem cells to replace lost or damaged bone marrow. For some people with lymphoma, it can be a possibility after receiving intense chemotherapy or radiation treatment.

6. Chimeric Antigen Receptor (CAR) T-cell Therapy: This cutting-edge immunotherapy alters a patient's own T-cells to identify and eliminate cancer cells. Treatment for some forms of lymphoma using CART-cell therapy has demonstrated encouraging outcomes.


7. A family of immunotherapy medications called bispecific monoclonal antibodies (bsAbs) has demonstrated potential in the management of myeloma. These antibodies are designed to attach to two distinct targets at the same time, usually an immune cell receptor and a surface marker for cancer cells. Because of their dual binding method, bsAbs can reroute immune cells so they can target and kill cancer cells selectively.


Share by: